Atrás
35
Rango del Día
$13.30
$13.78
Rango de 52 Semanas
$9.30
$15.68
Volumen
263,713
Promedio 50D / 200D
$13.60
/
$12.15
Cierre Anterior
$13.40
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -9.4 | 0.3 |
| P/B | 0.8 | 2.9 |
| ROE % | -8.5 | 3.7 |
| Net Margin % | -9.7 | 3.8 |
| Rev Growth 5Y % | -1.5 | 10.0 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
Hold
$23.00
+68.5%
Low: $20.00
High: $26.00
P/E Futuro
13.4
EPS Futuro
$1.00
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
710 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
$1.25
$1.25 – $1.25
|
740 M | 1 |
| FY2026 |
$1.00
$1.00 – $1.00
|
710 M | 1 |
Puntos Clave
Revenue declined -1.49% annually over 5 years
Debt/Equity of 0.17 — conservative balance sheet
Generating 43.10M in free cash flow
PEG of 0.09 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.44%
Capital efficient — spends only 4.51% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-1.49%
Revenue (1Y)1.95%
Earnings (1Y)N/A
FCF Growth (3Y)71.82%
Calidad
Return on Equity
-8.45%
ROIC-5.09%
Net Margin-9.68%
Op. Margin-8.78%
Seguridad
Debt / Equity
0.17
Current Ratio2.15
Interest Coverage-15.40
Valoración
P/E Ratio
-9.35
P/B Ratio0.82
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.95% | Revenue Growth (3Y) | 2.05% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -1.49% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 701.20M | Net Income (TTM) | -67.90M |
| ROE | -8.45% | ROA | -6.32% |
| Gross Margin | 49.77% | Operating Margin | -8.78% |
| Net Margin | -9.68% | Free Cash Flow (TTM) | 43.10M |
| ROIC | -5.09% | FCF Growth (3Y) | 71.82% |
| Safety | |||
| Debt / Equity | 0.17 | Current Ratio | 2.15 |
| Interest Coverage | -15.40 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.35 | P/B Ratio | 0.82 |
| P/S Ratio | 0.91 | PEG Ratio | 0.09 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 634.77M | Enterprise Value | 674.07M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 701.20M | 687.80M | 673.30M | 684.10M | 744.60M |
| Net Income | -67.90M | -392.10M | -61.80M | 50.50M | 6.30M |
| EPS (Diluted) | -1.46 | -8.53 | -1.33 | 1.07 | 0.13 |
| Gross Profit | 349.00M | 381.30M | 379.70M | 394.20M | 379.90M |
| Operating Income | -61.60M | 40.00M | 65.00M | 41.90M | 86.80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.07B | 1.15B | 1.69B | 1.79B | 1.60B |
| Total Liabilities | 295.50M | 325.70M | 456.10M | 495.70M | 333.00M |
| Shareholders' Equity | 778.20M | 828.50M | 1.24B | 1.29B | 1.27B |
| Total Debt | 129.10M | 170.20M | 209.10M | 277.00M | 187.50M |
| Cash & Equivalents | 89.80M | 107.70M | 87.70M | 127.70M | 118.50M |
| Current Assets | 355.40M | 393.40M | 487.00M | 624.10M | 427.60M |
| Current Liabilities | 165.20M | 165.90M | 234.60M | 191.00M | 139.20M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#550 of 827
Actividad Reciente
Entró
Deep Value Investing (Seth Klarman)
Mar 24, 2026